Literature DB >> 8127445

High-resolution 1H NMR spectroscopy of cerebrospinal fluid in spinal diseases.

F Koschorek1, W Offermann, J Stelten, W E Braunsdorf, U Steller, H Gremmel, D Leibfritz.   

Abstract

Twenty-nine patients with disk herniations, 7 patients with intraspinal tumors, 4 patients with multiple sclerosis and one patient with infection by borrelia have been studied by CT, myelography and/or MR. To gain information on the metabolism of central nervous system disease (CNS), and thus, to improve diagnosis the cerebrospinal fluid (CSF) was studied in all cases using high-resolution 1H NMR spectroscopy at 360 MHz. Seventeen metabolites could be identified in CSF in addition to the usual clinical chemical parameters. As compared to a control group discrimination of tumors from inflammation was possible by means of different metabolites and/or metabolite concentration. The CSF in disk herniations differed in the concentration of acetate from the control group. In CSF of tumors, multiple sclerosis and of infection by borrelia distinct differences in the concentrations of putrescine, citrate, valine, alpha-alanine, acetate, creatinine, glucose, beta-hydroxy-butyric acid, glutamine and creatine have been observed both as compared directly and in comparison to the control group. Thus, high-resolution 1H NMR spectroscopy of CSF gives speedy information on metabolism, since a variety of metabolites, usually examined only in different tests, can be studied in one single step. Thus, high-resolution 1H NMR spectroscopy supports imaging, especially MR, as morphological changes in diseases may be differentiated by means of different metabolite profiles. This assumption needs further confirmation on a prospective study with a larger patient population.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8127445     DOI: 10.1007/bf00383842

Source DB:  PubMed          Journal:  Neurosurg Rev        ISSN: 0344-5607            Impact factor:   3.042


  11 in total

1.  QUANTITATIVE THIN LAYER CHROMATOGRAPHY OF CEREBROSPINAL FLUID PHOSPHOLIPIDS.

Authors:  B M PHILLIPS; N ROBINSON
Journal:  Clin Chim Acta       Date:  1963-11       Impact factor: 3.786

2.  [Separation process for the quantitative determination of keto- and amino acids in small amounts of cerebrospinal fluid].

Authors:  E GRUNDIG
Journal:  Clin Chim Acta       Date:  1962-07       Impact factor: 3.786

3.  The amino acid content of human cerebrospinal fluid in normal individuals and in mental defectives.

Authors:  T L PERRY; R T JONES
Journal:  J Clin Invest       Date:  1961-08       Impact factor: 14.808

4.  An improved glucose-oxidase method for determining blood, C.S.F. and urine glucose levels.

Authors:  V MARKS
Journal:  Clin Chim Acta       Date:  1959-05       Impact factor: 3.786

5.  Cerebrospinal fluid: detection of tumors and disk herniations with MR spectroscopy.

Authors:  F Koschorek; H Gremmel; J Stelten; W Offermann; D Leibfritz
Journal:  Radiology       Date:  1988-06       Impact factor: 11.105

6.  [Behavior of free alpha-amino nitrogen in the cerebrospinal fluid and in the 24-hour urine of children with brain diseases of diverse genesis].

Authors:  W Hohenwallner; C Scheminsky
Journal:  Wien Klin Wochenschr       Date:  1973-01-19       Impact factor: 1.704

7.  Changes in free amino acids of cerebrospinal fluid and plasma in various neurological diseases.

Authors:  K Iijima; S Takase; K Tsumuraya; M Endo; K Itahara
Journal:  Tohoku J Exp Med       Date:  1978-10       Impact factor: 1.848

8.  Chronic hypoglycemia increases brain glucose transport.

Authors:  A L McCall; L B Fixman; N Fleming; K Tornheim; W Chick; N B Ruderman
Journal:  Am J Physiol       Date:  1986-10

9.  Differential expression of neural isozymes by human medulloblastomas and gliomas and neuroectodermal cell lines.

Authors:  P M Zeltzer; S L Schneider; P J Marangos; M H Zweig
Journal:  J Natl Cancer Inst       Date:  1986-09       Impact factor: 13.506

10.  Cerebral metabolism in brain tumor of mice studied by in vivo 31P-NMR spectroscopy.

Authors:  K Kato; A Ohsaka; K Matsushita; K Yoshikawa
Journal:  Biochem Biophys Res Commun       Date:  1987-04-14       Impact factor: 3.575

View more
  7 in total

1.  High-resolution nuclear magnetic resonance spectroscopic study of metabolites in the cerebrospinal fluid of patients with cervical myelopathy and lumbar radiculopathy.

Authors:  Hideki Nagashima; Yasuo Morio; Shunsuke Meshitsuka; Koji Yamane; Yoshiro Nanjo; Ryota Teshima
Journal:  Eur Spine J       Date:  2010-05-20       Impact factor: 3.134

2.  Metabolic profiling of CSF: evidence that early intervention may impact on disease progression and outcome in schizophrenia.

Authors:  Elaine Holmes; Tsz M Tsang; Jeffrey T-J Huang; F Markus Leweke; Dagmar Koethe; Christoph W Gerth; Brit M Nolden; Sonja Gross; Daniela Schreiber; Jeremy K Nicholson; Sabine Bahn
Journal:  PLoS Med       Date:  2006-08       Impact factor: 11.069

3.  Magnetic resonance spectroscopy for the study of cns malignancies.

Authors:  Victor Ruiz-Rodado; Jeffery R Brender; Murali K Cherukuri; Mark R Gilbert; Mioara Larion
Journal:  Prog Nucl Magn Reson Spectrosc       Date:  2020-12-02       Impact factor: 9.795

Review 4.  Contribution of Metabolomics to Multiple Sclerosis Diagnosis, Prognosis and Treatment.

Authors:  Marianna Gabriella Rispoli; Silvia Valentinuzzi; Giovanna De Luca; Piero Del Boccio; Luca Federici; Maria Di Ioia; Anna Digiovanni; Eleonora Agata Grasso; Valeria Pozzilli; Alessandro Villani; Antonio Maria Chiarelli; Marco Onofrj; Richard G Wise; Damiana Pieragostino; Valentina Tomassini
Journal:  Int J Mol Sci       Date:  2021-10-15       Impact factor: 5.923

5.  Inflammatory multiple-sclerosis plaques generate characteristic metabolic profiles in cerebrospinal fluid.

Authors:  Norbert W Lutz; Angèle Viola; Irina Malikova; Sylviane Confort-Gouny; Bertrand Audoin; Jean-Philippe Ranjeva; Jean Pelletier; Patrick J Cozzone
Journal:  PLoS One       Date:  2007-07-04       Impact factor: 3.240

6.  The 1H NMR profile of healthy dog cerebrospinal fluid.

Authors:  Mihai Musteata; Alina Nicolescu; Gheorghe Solcan; Calin Deleanu
Journal:  PLoS One       Date:  2013-12-23       Impact factor: 3.240

Review 7.  Low Tissue Creatine: A Therapeutic Target in Clinical Nutrition.

Authors:  Sergej M Ostojic
Journal:  Nutrients       Date:  2022-03-15       Impact factor: 5.717

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.